- Home
- RPRX vs IEX Comparison
RPRX vs IEX Comparison
Compare RPRX & IEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPRX
- IEX
- Stock Information
- Founded
- RPRX 1996
- IEX 1987
- Country
- RPRX United States
- IEX United States
- Employees
- RPRX N/A
- IEX N/A
- Industry
- RPRX Biotechnology: Pharmaceutical Preparations
- IEX Fluid Controls
- Sector
- RPRX Health Care
- IEX Industrials
- Exchange
- RPRX Nasdaq
- IEX Nasdaq
- Market Cap
- RPRX 13.9B
- IEX 13.8B
- IPO Year
- RPRX 2020
- IEX 1991
- Fundamental
- Price
- RPRX $35.59
- IEX $183.35
- Analyst Decision
- RPRX Strong Buy
- IEX Buy
- Analyst Count
- RPRX 3
- IEX 8
- Target Price
- RPRX $48.33
- IEX $222.29
- AVG Volume (30 Days)
- RPRX 3.5M
- IEX 762.8K
- Earning Date
- RPRX 08-06-2025
- IEX 07-30-2025
- Dividend Yield
- RPRX 2.48%
- IEX 1.55%
- EPS Growth
- RPRX 37.60
- IEX N/A
- EPS
- RPRX 2.45
- IEX 6.30
- Revenue
- RPRX $2,263,845,000.00
- IEX $3,282,600,000.00
- Revenue This Year
- RPRX $29.35
- IEX $5.97
- Revenue Next Year
- RPRX $7.58
- IEX $4.04
- P/E Ratio
- RPRX $14.47
- IEX $29.06
- Revenue Growth
- RPRX 1.13
- IEX 1.66
- 52 Week Low
- RPRX $24.05
- IEX $153.36
- 52 Week High
- RPRX $36.89
- IEX $238.22
- Technical
- Relative Strength Index (RSI)
- RPRX 52.61
- IEX 55.80
- Support Level
- RPRX $35.24
- IEX $177.09
- Resistance Level
- RPRX $36.89
- IEX $182.84
- Average True Range (ATR)
- RPRX 0.62
- IEX 3.73
- MACD
- RPRX -0.14
- IEX 0.39
- Stochastic Oscillator
- RPRX 22.16
- IEX 68.75
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About IEX IDEX Corporation
Idex manufactures pumps, flow meters, valves, and fluidic systems for customers in a variety of end markets, including industrial, fire and safety, life science, and water. The firm's business is organized into three segments: fluid and metering technologies, health and science technologies, and fire and safety and diversified products. Based in Lake Forest, Illinois, Idex has manufacturing operations in over 20 countries and has over 7,000 employees. The company generated $3.3 billion in revenue in 2024.